Sinovac Biotech annual capital expenditures (capex)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Capital Expenditures (CapEx) Growth & History (SVA)
Sinovac Biotech's capital expenditures (capex) was $48.9M for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $48.9M | −$47.0M | −49.02% |
| 2024 | 2024-12-31 | $96.0M | −$60.2M | −38.55% |
| 2023 | 2023-12-31 | $156.2M | −$157.7M | −50.24% |
| 2022 | 2022-12-31 | $313.9M | −$280.4M | −47.18% |
| 2021 | 2021-12-31 | $594.2M | $466.7M | +366.10% |
| 2020 | 2020-12-31 | $127.5M | $116.9M | +1099.53% |
| 2019 | 2019-12-31 | $10.6M | $5.0M | +89.35% |
| 2018 | 2018-12-31 | $5.6M | −$6.3M | −52.89% |
| 2017 | 2017-12-31 | $11.9M | −$739,000 | −5.84% |
| 2016 | 2016-12-31 | $12.7M | $7.4M | +138.80% |
| 2015 | 2015-12-31 | $5.3M | −$5.6M | −51.44% |
| 2014 | 2014-12-31 | $10.9M | $5.8M | +112.60% |
| 2013 | 2013-12-31 | $5.1M | −$11.0M | −68.23% |
| 2012 | 2012-12-31 | $16.2M | $699,000 | +4.52% |
| 2011 | 2011-12-31 | $15.5M | −$9.4M | −37.72% |
| 2010 | 2010-12-31 | $24.8M | $20.5M | +474.46% |
| 2009 | 2009-12-31 | $4.3M | — | — |
Sinovac Biotech capital expenditures (capex) trends
Over the last five fiscal years, Sinovac Biotech's capital expenditures (capex) decreased from $127.5M to $48.9M, a change of −$78.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗